Dillon & Associates Inc. Grows Position in Colgate-Palmolive (NYSE:CL)

Dillon & Associates Inc. boosted its stake in Colgate-Palmolive (NYSE:CL) by 0.5% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,104 shares of the company’s stock after purchasing an additional 150 shares during the quarter. Dillon & Associates Inc.’s holdings in Colgate-Palmolive were worth $2,830,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $26,000. Centricity Wealth Management LLC purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $27,000. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $32,000. Briaud Financial Planning Inc purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $32,000. Finally, Wintrust Investments LLC purchased a new stake in Colgate-Palmolive during the fourth quarter worth approximately $33,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have issued reports on CL. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Raymond James reissued an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Friday, March 14th. Finally, Stifel Nicolaus reduced their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and an average target price of $101.72.

Colgate-Palmolive Stock Up 0.0 %

Shares of NYSE:CL opened at $90.30 on Monday. The stock has a market capitalization of $73.28 billion, a price-to-earnings ratio of 25.65, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company’s fifty day moving average is $89.33 and its two-hundred day moving average is $94.07. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the company earned $0.87 earnings per share. Equities analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.30%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.50. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Colgate-Palmolive declared that its board has approved a stock repurchase program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to buy up to 6.8% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s board believes its shares are undervalued.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.